These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 451366)

  • 41. [Pulmonary sarcoidosis simulating primary acute interstitial fibrosis at presentation. Clinical, radiologic, functional and bronchoalveolar cytologic study in 3 cases].
    Dugas M; Wallaert B; Bart F; Gosselin B; Tonnel AB; Voisin C
    Rev Mal Respir; 1989; 6(3):243-50. PubMed ID: 2740589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serial pulmonary function tests in fibrosing alveolitis.
    Benson MK; Hughes DT
    Br J Dis Chest; 1972 Jan; 66(1):33-44. PubMed ID: 5017931
    [No Abstract]   [Full Text] [Related]  

  • 43. Pulmonary sarcoidosis presenting with unusual roentgenographic manifestations.
    Rubinstein I; Solomon A; Baum GL; Hiss Y
    Eur J Respir Dis; 1985 Nov; 67(5):335-40. PubMed ID: 4085585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing.
    El Maghraoui A; Chaouir S; Abid A; Bezza A; Tabache F; Achemlal L; Abouzahir A; Ghafir D; Ohayon V; Archane MI
    Clin Rheumatol; 2004 Apr; 23(2):123-8. PubMed ID: 15045626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restrictive lung disease: the view from pathology.
    Wyatt JP; Ishikawa S
    Hum Pathol; 1970 Jun; 1(2):289-303. PubMed ID: 5521728
    [No Abstract]   [Full Text] [Related]  

  • 46. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J; Klar B; Hardung-Backes M
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemoptysis in sarcoidosis.
    Chang JC; Driver AG; Townsend CA; Kataria YP
    Sarcoidosis; 1987 Mar; 4(1):49-54. PubMed ID: 3589193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transbronchial lung biopsy in diffuse pulmonary disease.
    Zajaczkowska J
    Z Erkr Atmungsorgane; 1988; 170(2):132-9. PubMed ID: 3400287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sarcoidosis: a clinical, roentagenographic and pathological survey.
    Nessan VJ; Malin J; Parks SD
    West J Med; 1981 Nov; 135(5):353-9. PubMed ID: 7340129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Open biopsy of the lungs in bilateral disseminated lesions].
    Slepukha IM; Radionov BV; Suslov EI
    Probl Tuberk; 1988; (9):18-21. PubMed ID: 3231615
    [No Abstract]   [Full Text] [Related]  

  • 51. Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA.
    Chinet T; Dusser D; Labrune S; Collignon MA; Chrétien J; Huchon GJ
    Am Rev Respir Dis; 1990 Feb; 141(2):445-9. PubMed ID: 2405760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sarcoidosis. A clinical study with special reference to the choice of biopsy procedure.
    Rasmussen SM; Neukirch F
    Acta Med Scand; 1976; 199(3):209-16. PubMed ID: 1258702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stage III sarcoidosis.
    Mohanty KC; Parekh N
    Indian J Chest Dis Allied Sci; 1987; 29(3):178-81. PubMed ID: 3428944
    [No Abstract]   [Full Text] [Related]  

  • 54. TruCut needle biopsy in sarcoidosis. Relationship between histology of the biopsy specimens and radiographic features and pulmonary function.
    Tukiainen P; Taskinen E; Korhola O; Valle M; Maasilta P
    Br J Dis Chest; 1983 Jul; 77(3):243-8. PubMed ID: 6615702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of transbronchial and open biopsies in chronic infiltrative lung diseases.
    Wall CP; Gaensler EA; Carrington CB; Hayes JA
    Am Rev Respir Dis; 1981 Mar; 123(3):280-5. PubMed ID: 7224338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffusing capacity and forced vital capacity in 5,003 asbestos-exposed workers: relationships to interstitial fibrosis (ILO profusion score) and pleural thickening.
    Miller A; Warshaw R; Nezamis J
    Am J Ind Med; 2013 Dec; 56(12):1383-93. PubMed ID: 24038345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography.
    Afeltra A; Zennaro D; Garzia P; Gigante A; Vadacca M; Ruggiero A; Dardes N; Navajas MF; Zobel BB; Amoroso A
    Scand J Rheumatol; 2006; 35(5):388-94. PubMed ID: 17062440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease.
    Hunninghake GW; Kawanami O; Ferrans VJ; Young RC; Roberts WC; Crystal RG
    Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):407-12. PubMed ID: 7224352
    [No Abstract]   [Full Text] [Related]  

  • 59. [Surgical pulmonary biopsy in diffuse interstitial pneumopathies].
    Hallet JF; Feintrenie X; Martinet Y; Borrelly J; Lamy P
    Rev Pneumol Clin; 1985; 41(6):397-404. PubMed ID: 3834573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis?
    Lynch DA; Newell JD; Logan PM; King TE; Müller NL
    AJR Am J Roentgenol; 1995 Oct; 165(4):807-11. PubMed ID: 7676971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.